Protective Effect of Resveratrol, A Red Wine Constituent Polyphenol, on Rats Subjected to Portal Vein Thrombosis

Transplantation Proceedings

Volumn 40, Issue 1, 2008, Pages 290-292

  Kirimlioglu, V ^a   Sozen, H ^a   Turkoglu, S ^a   Haberal, M ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; MALONALDEHYDE; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; NONHUMAN; OUTCOME ASSESSMENT; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RAT; WINE;

ANIMALS; ANTIOXIDANTS; CYCLIC AMP; GLUTATHIONE; MALONDIALDEHYDE; PORTAL VEIN; RATS; STILBENES; VENOUS THROMBOSIS;

EID: 38749149541     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2007.11.051     Document Type: Article

References (13)

1. Davidson B.R., Gibson M., Dick R., et al. Incidence, risk factors, management, and outcome of portal vein abnormalities at orthotopic liver transplantation. Transplantation 57 (1994) 1174
2. Settmacher U., Nussler N.C., Glanemann M., et al. Venous complications after orthotopic liver transplantation. Clin Transplant 14 (2000) 235
3. Seu P., Shackleton C.R., Shaked A., et al. Improved results of liver transplantation in patients with portal vein thrombosis. Arch Surg 131 (1996) 840
4. Sainz-Barriga M., Baccarani U., Risaliti A., et al. Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report. Transplant Proc 36 (2004) 558
5. Mihara M., and Uchiyama M. Effects of antioxidants on the TBA reaction of various rat liver homogenates. Biochem Med 30 (1983) 131
6. Kirimlioglu V., Ara C., Yilmaz M., et al. Resveratrol, a red wine constituent polyphenol, protects gastric tissue against the oxidative stress in cholestatic rats. Dig Dis Sci 51 (2006) 298
7. Kuo P.L., Chiang L.C., and Lin C.C. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci 72 (2002) 23
8. Pace-Asciak C.R., Hahn S., Diamandis E.P., et al. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 235 (1995) 207
9. Jang D.S., Kang B.S., Ryu S.Y., et al. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. Biochem Pharmacol 57 (1999) 705
10. Karabulut A.B., Kirimlioglu V., Kirimlioglu H., et al. Protective effects of resveratrol on spleen and ileum in rats subjected to ischemia-reperfusion. Transplant Proc 38 (2006) 375
11. Blumenstein I., Keseru B., Wolter F., et al. The chemopreventive agent resveratrol stimulates cyclic AMP-dependent chloride secretion in vitro. Clin Cancer Res 11 (2005) 5651
12. Russo P., Tedesco I., Russo M., et al. Effects of de-alcoholated red wine and its phenolic fractions on platelet aggregation. Nutr Metab Cardiovasc Dis 11 (2001) 25
13. Sun Z.J., Pan C.E., Liu H.S., et al. Anti-hepatoma activity of resveratrol in vitro. World J Gastroenterol 8 (2002) 79